• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英国早期发现艾滋病毒感染的经济和健康影响。

Economic and health implications from earlier detection of HIV infection in the United Kingdom.

作者信息

Zah Vladimir, Toumi Mondher

机构信息

Ecole Doctoral Interdisciplinaire Sciences-Santé (EDISS), University of Lyon, Lyon, France; ZRx Outcomes Research Inc., Mississauga, Canada.

Ecole Doctoral Interdisciplinaire Sciences-Santé (EDISS), University of Lyon, Lyon, France.

出版信息

HIV AIDS (Auckl). 2016 Mar 15;8:67-74. doi: 10.2147/HIV.S96713. eCollection 2016.

DOI:10.2147/HIV.S96713
PMID:27073328
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4806762/
Abstract

PURPOSE

To model the budget and survival impact of implementing interventions to increase the proportion of HIV infections detected early in a given UK population.

PATIENTS AND METHODS

A Microsoft Excel decision model was designed to generate a set of outcomes for a defined population. Survival was modeled on the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study extrapolated to a 5-year horizon as a constant hazard. Hazard rates were specific to age, sex, and whether detection was early or late. The primary outcomes for each year up to 5 years were: annual costs, numbers of infected cases, hospital admissions, and surviving cases. Three locations in the UK were chosen to model outcomes across a range of HIV prevalence areas: Lambeth, Southwark, and Lewisham (LSL), Greater Manchester Cluster (GMC), and Kent and Medway (K&M).

RESULTS

In LSL, the projected cumulative cost savings over 5 years were £3,210,206 or £5,290,206 when including the value of the 104 life-years saved. Savings were insensitive to transmission rates, but sensitive in direct proportion to the percentage shift from late to early detection. In GMC, savings were in a similar proportion to LSL, but the magnitude was smaller, as a consequence of the lower base-case HIV prevalence. In K&M, with a smaller population and lower HIV prevalence than GMC, savings were commensurately smaller (£733,202 cumulatively over 5 years).

CONCLUSION

The results strengthen the rationale for implementing increased testing in high prevalence areas. However, in areas of low prevalence, it is unlikely that costs will be returned over a 5-year period.

摘要

目的

建立一个模型,以评估实施干预措施对增加英国特定人群中早期检测出的艾滋病毒感染比例所产生的预算和生存影响。

患者与方法

设计了一个Microsoft Excel决策模型,以生成特定人群的一组结果。生存情况以欧洲观察性艾滋病毒流行病学研究协作组(COHERE)的研究为模型,外推至5年,采用恒定风险率。风险率因年龄、性别以及检测是早期还是晚期而异。直至5年的每年主要结果为:年度成本、感染病例数、住院人数和存活病例数。选择英国的三个地点来模拟不同艾滋病毒流行地区的结果:兰贝斯、南华克和刘易舍姆(LSL)、大曼彻斯特集群(GMC)以及肯特和梅德韦(K&M)。

结果

在LSL,若将节省的104个生命年的价值计算在内,预计5年累计成本节省为3,210,206英镑或5,290,206英镑。节省对传播率不敏感,但与从晚期检测向早期检测转变的百分比成正比。在GMC,节省比例与LSL相似,但幅度较小,这是由于基础病例艾滋病毒流行率较低。在K&M,由于人口比GMC少且艾滋病毒流行率较低,节省幅度相应较小(5年累计为733,202英镑)。

结论

结果强化了在高流行地区增加检测的合理性。然而,在低流行地区,5年内不太可能收回成本。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4b7/4806762/8b56d69ca352/hiv-8-067Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4b7/4806762/7284418f5728/hiv-8-067Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4b7/4806762/c9d7f6187c4b/hiv-8-067Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4b7/4806762/8b56d69ca352/hiv-8-067Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4b7/4806762/7284418f5728/hiv-8-067Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4b7/4806762/c9d7f6187c4b/hiv-8-067Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4b7/4806762/8b56d69ca352/hiv-8-067Fig3.jpg

相似文献

1
Economic and health implications from earlier detection of HIV infection in the United Kingdom.英国早期发现艾滋病毒感染的经济和健康影响。
HIV AIDS (Auckl). 2016 Mar 15;8:67-74. doi: 10.2147/HIV.S96713. eCollection 2016.
2
Comparison of economic and health implications from earlier detection of HIV infection in the United Kingdom and Poland.
Przegl Epidemiol. 2015;69(4):765-72, 899-903.
3
The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.吸烟及降低吸烟率的经济影响:证据综述
Tob Use Insights. 2015 Jul 14;8:1-35. doi: 10.4137/TUI.S15628. eCollection 2015.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
6
7
Tuberculosis结核病
8
[A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].[在意大利国家和地区层面使用RIX4414疫苗对轮状病毒进行广泛疫苗接种的全面经济评估]
Ann Ig. 2013 Jan-Feb;25(1):43-56. doi: 10.7416/ai.2013.1905.
9
Economic and health-related quality-of-life (HRQoL) comparison of lopinavir/ritonavir (LPV/r) and atazanavir plus ritonavir (ATV+RTV) based regimens for antiretroviral therapy (ART)-naïve and -experienced United Kingdom patients in 2011.2011 年英国初治和经治的抗逆转录病毒治疗(ART)患者中洛匹那韦/利托那韦(LPV/r)和阿扎那韦/利托那韦(ATV+RTV)方案的经济学和与健康相关的生活质量(HRQoL)比较。
J Med Econ. 2012;15(4):796-806. doi: 10.3111/13696998.2012.691927. Epub 2012 Jun 7.
10
Reducing the spread of HIV infection in sub-Saharan Africa: some demographic and economic implications.减少撒哈拉以南非洲地区艾滋病毒感染的传播:一些人口和经济影响。
AIDS. 1990 Jan;4(1):47-56. doi: 10.1097/00002030-199001000-00007.

本文引用的文献

1
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012.英国艾滋病协会 2012 年抗逆转录病毒治疗艾滋病病毒 1 型阳性成人治疗指南。
HIV Med. 2012 Sep;13 Suppl 2:1-85. doi: 10.1111/j.1468-1293.2012.01029.x.
2
The cost-effectiveness of early access to HIV services and starting cART in the UK 1996-2008.英国 1996-2008 年早期获得 HIV 服务和开始 cART 的成本效益。
PLoS One. 2011;6(12):e27830. doi: 10.1371/journal.pone.0027830. Epub 2011 Dec 14.
3
Projected life expectancy of people with HIV according to timing of diagnosis.
根据诊断时间预测 HIV 感染者的预期寿命。
AIDS. 2012 Jan 28;26(3):335-43. doi: 10.1097/QAD.0b013e32834dcec9.
4
The Direct Medical Costs of Late Presentation (<350/mm) of HIV Infection over a 15-Year Period.15年期间HIV感染延迟就诊(<350/mm)的直接医疗费用。
AIDS Res Treat. 2012;2012:757135. doi: 10.1155/2012/757135. Epub 2011 Aug 29.
5
Cost-effectiveness of early treatment with first-line NNRTI-based HAART regimens in the UK, 1996-2006.英国 1996-2006 年一线基于 NNRTI 的高效抗逆转录病毒治疗方案早期治疗的成本效益。
PLoS One. 2011;6(5):e20200. doi: 10.1371/journal.pone.0020200. Epub 2011 May 25.
6
HIV transmission and high rates of late diagnoses among adults aged 50 years and over.HIV 传播和 50 岁及以上成年人晚期诊断率高。
AIDS. 2010 Aug 24;24(13):2109-15. doi: 10.1097/QAD.0b013e32833c7b9c.
7
Searching for cost effectiveness thresholds in the NHS.在英国国家医疗服务体系中寻找成本效益阈值。
Health Policy. 2009 Aug;91(3):239-45. doi: 10.1016/j.healthpol.2008.12.010. Epub 2009 Jan 24.
8
Cost-effectiveness of HIV screening in patients older than 55 years of age.55岁以上患者HIV筛查的成本效益
Ann Intern Med. 2008 Jun 17;148(12):889-903. doi: 10.7326/0003-4819-148-12-200806170-00002.
9
Cost-effectiveness of HIV testing and treatment in the United States.美国艾滋病病毒检测与治疗的成本效益
Clin Infect Dis. 2007 Dec 15;45 Suppl 4(Suppl 4):S248-54. doi: 10.1086/522546.
10
The high cost of medical care for patients who present late (CD4 <200 cells/microL) with HIV infection.对于出现较晚(CD4细胞计数<200个/微升)的HIV感染患者,医疗费用高昂。
HIV Med. 2004 Mar;5(2):93-8. doi: 10.1111/j.1468-1293.2004.00193.x.